Verantos named the 2026 winner of the Real-World Evidence & Data Analytics category in the inaugural Fierce AI Innovation Awards

The Fierce AI Innovation Awards recognize organizations that are moving beyond pilots to deliver measurable impact. This program highlights how AI is being applied across the value chain from R&D and clinical trials to commercialization, manufacturing and care delivery.

Submissions were evaluated on the following criteria:

• Innovation: How differentiated and forward-thinking is the AI application?
• Impact: What measurable outcomes were achieved (efficiency, cost, speed, patient outcomes, etc.)?
• Execution: How effectively was the solution implemented and scaled?
• Scalability: Can the solution be expanded across programs, functions, or organizations?
• Industry Relevance: How well does the work address a critical challenge in biotech, pharma, or healthcare?